CWBR — CohBar Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Morphogenesis And CohBar Announce Positive Results From Phase 1B Trial Of IFX-HU2.0 Personalized Cancer Vaccine, In Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) And Cutaneous Squamous Cell Carcinoma (CSCC)
U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium
CohBar surges on merger agreement with Morphogenesis
U.S. STOCKS ON THE MOVE-Chevron, Broadcom, Williams-Sonoma
U.S. STOCKS ON THE MOVE-Yelp, Shutterstock, TCS
CohBar surges on merger agreement with Morphogenesis
Brief: CohBar, Inc. And Morphogenesis, Inc. Enter Into Definitive Merger Agreement
Brief: CohBar Reports Third Quarter 2022 Financial Results, Highlights Recent Corporate Progress
CohBar Inc reports results for the quarter ended in September - Earnings Summary
CohBar Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: Cohbar To Announce 2022 Third Quarter Financial Results On November 8
Brief: CohBar Announces Reverse Stock Split
Brief: CohBar Reports Q2 Results
Brief: CohBar Appoints Effie Tozzo To Its Board Of Directors
CohBar Inc reports results for the quarter ended in March - Earnings Summary
CohBar Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: CohBar Announces Extension Of Nasdaq Compliance Period
CohBar Inc reports results for the quarter ended in December - Earnings Summary
Brief: CohBar Reports Fourth Quarter Loss Per Share Of $0.04